World Health Organization Department of HIV/AIDS Estimates of ARV Treatment Needs 2003-2005.

Slides:

Advertisements

Similar presentations

Health Doing Business with the World - The new role of corporate leadership in global development Geneva, September 2007 World Business Council for Sustainable.

Advertisements

Comprehensive Review of National Development Strategies Lesotho.

UNDP Regional Bureau for Africa MDG-based national Development Planning Training Workshop HIV/AIDS Assessments Dar Es Salaam February 27 - March 3, 2006.

Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.

Snap Shot of OVC Planning in the Caribbean. Facts Three quarters of the 250,000 people infected wit HIV live in two countries: Haiti and Dominican Republic.

HIV/AIDS Weakens the Immune System

Multinational Comparisons of Health Systems Data, 2007 Bianca K. Frogner, Meghan Bishop, and Gerard F. Anderson, Ph.D. Johns Hopkins University November.

1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.

HIV Situation in India Dr Sunil Gaikwad.

A brief overview of ART services at QECH, Malawi Kudzala Aub. MMEDsc. Student Sr. Lead ART Clinician/ HIV Medicine Registrar.

WHO/WIPO/WTO Meeting Geneva, July 2010 Procurement and Supply Management Approach Monitoring Availability and Pricing WHO/WIPO/WTO technical Symposium.

Estimated adult (15–49 years) HIV prevalence rate (%) globally and in Sub-Saharan Africa, 1990–2007 Year Adult HIV prevalence rate (%)

2008 Report on the global AIDS epidemic Report on the global AIDS epidemic A global view of HIV infection 33 million people [30–36 million] living.

HIV and Harm Reduction Winning on policy front : Faltering on Implementation JVR Prasada Rao, UNAIDS XVIII International Harm Reduction Conference Warsaw,

Asia and Pacific Overview of the HIV Epidemic and Response JVR Prasada Rao Regional Support Team Asia & Pacific Bangkok ICAAP, Kobe, July 2005.

Innovative Financing : Exceptionality of AIDS Brookings Institution and the Health Financing Task Force Washington D.C. 25 July 2006 Dr Peter Piot, UNAIDS.

UN Strategic Plan on HIV/AIDS Midterm Performance review (2001 – 2003) Monitoring and Evaluation Reference Group 29 July 2003.

HIV/AIDS Estimation and Projections: Overview of Methods and Activities.

UNGASS Country reports Lessons learned MERG Meeting Geneva July

1 December 2006 e Total39.5 million [34.1 – 47.1 million] Adults37.2 million [32.1 – 44.5 million] Women17.7 million [15.1 – 20.9 million] Children under.

1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.

How can we tailor the delivery of the TB/HIV package to IDU? David H.-U. Haerry European AIDS Treatment Group (European Community Advisory Board, Policy.

TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,

PROCURING AND DISTRIBUTING ARVs AND OTHER A.R.T COMMODITIES IN MALAWI Technical Briefing for Consultants in Procurement and Supply Management for HIV,

Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.

Harmonization of Reporting Requirements Tanzania

Accessing to ARV in HIV/AIDS care and treatment programme in Vietnam Accessing to ARV in HIV/AIDS care and treatment programme in Vietnam Dr.Nguyen Van.

Oklahomas Toxics Program Proposed Funding Air Quality Council January 19, 2005.

No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.

Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.

The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.

Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.

Core epidemiological slides HIV/AIDS estimates

UNAIDS – Children and HIV in Jamaica and the Caribbean region

Scaling up ART in Sénégal: specifics needs for strategic information Mame Awa Toure MD, MSc AIDS/STI Division, MOH Senegal.

From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.

The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,

Stakeholders meeting for priority medicines for Europe and the world Role of Public Private Partnerships 4 October 2004 Brussels Dr. Frans Van den Boom,

TOWARDS UNIVERSAL ACCESS

Source: Financial Times of London Global Banks 1999 – 2009 “Changing of the Guard”

Guthrie, T., Kioko, U., Chitama, D., Asante, F., Chitsomia, A., Madadume, B. Inaugural Conference of the African Health Economics and Policy Association.

The TB situation in the Americas: Reaching the MDGs on TB Dr. Jarbas Barbosa Area Manager, Health Surveillance & Disease Management 23 March 2007.

World Health Organization

HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines Treatment Recommendations for Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer.

80:20 Our Unequal World.

Dr. S.K CHATURVEDI Dr. KANUPRIYA CHATURVEDI

"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-

ART: The Basics William Aldis World Health Organization Bangkok, September 14, 2005.

Ending AIDS by 2030 World AIDS Day Commemoration Addis Ababa, Ethiopia, 25 November 2014.

00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.

Treatment Optimization in Latin America and the Caribbean: How can the GF contribute?

Total health ODA commitments, US$ Billions.

HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.

Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.

1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.

Abt Associates Inc. In collaboration with: I Aga Khan Foundation I Bitrán y Asociados I BRAC University I Broad Branch Associates I Deloitte Consulting,

Main achievements and further developments 2006 and beyond: Overcoming HIV/AIDS epidemic in Ukraine (programme (programme supported by the Global Fund)

Global summary of the HIV and AIDS epidemic, December 2003

Contents - HIV global slides

Contents Global impact 2.Service cascade 3. Policies and WHO support.

"3 by 5" progress December 2005.

Global summary of the HIV and AIDS epidemic, December 2004

Contents - HIV global slides

Global summary of the AIDS epidemic

July 21, 2016 Potential Domestic Source Financing for Scaled Up Antiretroviral Therapy in 97 Countries, 2016–2020 Arin Dutta, Catherine Barker, and Ashley.

AIDS-related deaths the lowest this century

Contents - HIV global slides

Contents - HIV global slides

Contents Global impact 2.Service cascade 3. Policies and WHO support.

Presentation transcript:

World Health Organization Department of HIV/AIDS Estimates of ARV Treatment Needs

World Health Organization Department of HIV/AIDS Estimating treatment needs Sum of newly needing treatment and those on treatment already: –Newly needing treatment in 2003 = the projected number of deaths in year the projected number of deaths of deaths in 2004 –Already on treatment at the beginning of 2003 with a survival rate of 80%

World Health Organization Department of HIV/AIDS Projected Number of Adult Deaths by Region,

World Health Organization Department of HIV/AIDS ARV therapy coverage estimates, end of ,000 people on treatment out of 5.5 million in need: 5% coverage

World Health Organization Department of HIV/AIDS The Road to 3 Million on Treatment: Doubling of numbers every year

World Health Organization Department of HIV/AIDS Increasing needs for ARV therapy Based on deaths and increasing coverage

World Health Organization Department of HIV/AIDS Number of People on Treatment by Region,

World Health Organization Department of HIV/AIDS Proportion of People in Need who are on Treatment by Region,

World Health Organization Department of HIV/AIDS Strong commitment from developing countries 58 of the 90 countries with national HIV/AIDS strategic plans have incorporated ART into the plans and have defined specific ART coverage targets

World Health Organization Department of HIV/AIDS … some targets in national plans/proposals for people on ART by 2005 (total 300,000) Strong commitment from developing countries

World Health Organization Department of HIV/AIDS Substantial resources are becoming available Approved $860 million for HIV/AIDS for two years covering: 70 programmes 57 countries 30% for drugs Available $1 billion & $155 million for HIV/AIDS programs in Africa and the Caribbean, respectively, covering: 23 countries include health infrastructure and drugs for ART Proposed $15 billion for HIV/AIDS for 5 years covering: $10 billion as new money Africa and Caribbean countries to include ART programmes Global Fund World Bank - MAP US Government

World Health Organization Department of HIV/AIDS Global Fund: Majority of funds for drugs and commodities Administrative costs (6%) Human Resources (9%) Training/planning (11%) Commodities/Products (26%) Drugs (30%) Expenditure items for recommended components 100% = USD 866 million Infrastructure/Equipment (9%) Other (4%) Monitoring & Evaluation (5%)

World Health Organization Department of HIV/AIDS GLOBAL FUND Treatment Activities in Approved Proposals Percent of HIV/AIDS proposals integrating different treatment activities % % % % %